Literature DB >> 1622841

Differential metastatic capacity of three AKR lymphoma variants.

J Leibovici1, O Klein, H Argaman, G Klorin, M Michowitz.   

Abstract

The comprehension of tumour progression has advanced due to the use of various models, the most rewarding being probably the study of malignancy variants derived from the same tumour. In the present study the biological behaviours of three AKR lymphoma variants were compared. The three variants, TAU-33, TAU-38 and TAU-39, differed markedly in biological behaviour. The TAU-39 variant formed very large 'primary tumours', TAU-33 produced local growths of intermediate size, and TAU-38 formed small s.c. tumours. However, the metastatic potentials of the variants were inversely related to their ability to produce local tumours. According to various parameters (spread to organs, cachexia and mice mortality rate), the variant of highest metastatic potential was TAU-38, the one of intermediate ability TAU-33 and the TAU-39 had the least aggressive behaviour. A lack of difference in invasive capacity as well as a similar ranking of malignancy by both s.c. and i.v. inoculation indicate a differential behaviour in late metastasis phase. Tumour progression models may contribute to a better understanding of this threatening process and to testing of new treatment modalities suitable for cancer at different stages.

Entities:  

Mesh:

Year:  1992        PMID: 1622841      PMCID: PMC2002336     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  23 in total

Review 1.  The structure and function of intercellular junctions in cancer.

Authors:  R S Weinstein; F B Merk; J Alroy
Journal:  Adv Cancer Res       Date:  1976       Impact factor: 6.242

2.  Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.

Authors:  E Frei; F M Schabel; A Goldin
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

3.  Relationship between white blood cell count and diagnosis and therapeutic response in AKR mice with spontaneous leukemia (lymphoma).

Authors:  M Kende; A I Goldberg; J P Glynn; N Mantel; A Goldin
Journal:  Cancer Chemother Rep       Date:  1972-12

4.  Follicular lymphomas: possibility that they are benign tumors of the lymphoid system.

Authors:  E S Jaffe
Journal:  J Natl Cancer Inst       Date:  1983-03       Impact factor: 13.506

5.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen.

Authors:  L A Liotta; K Tryggvason; S Garbisa; I Hart; C M Foltz; S Shafie
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

6.  Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain.

Authors:  R S Kerbel; R R Twiddy; D M Robertson
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

7.  Surface markers and prognostic factors in acute lymphoblastic leukemia.

Authors:  I Tsukimoto; K Y Wong; B C Lampkin
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

8.  Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.

Authors:  I Vlodavsky; V Schirrmacher; Y Ariav; Z Fuks
Journal:  Invasion Metastasis       Date:  1983

9.  Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells.

Authors:  P De Baetselier; E Gorelik; Z Eshhar; Y Ron; S Katzav; M Feldman; S Segal
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

10.  Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs.

Authors:  J Leibovici
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.